Atherectomy Devices Market Size to Reach USD 1.93 Billion by 2032, Growing at a CAGR of 8.16% | SNS Insider

According to a comprehensive study by SNS Insider, the Atherectomy Devices Market size was valued at USD 1.03 billion in 2024 and is projected to reach USD 1.93 billion by 2032, exhibiting a robust CAGR of 8.16% during 2025–2032. The rapid increase in peripheral artery disease (PAD) cases, advancements in minimally invasive treatments, and the rising adoption of endovascular devices are the major factors fueling market expansion globally.

Atherectomy devices are designed to remove atherosclerotic plaque from blood vessels and restore normal blood flow. With the growing aging population and lifestyle-related disorders such as diabetes and hypertension, the need for effective plaque removal devices is increasing significantly. Healthcare providers and interventional cardiologists prefer atherectomy procedures due to their precision, faster recovery, and reduced risk of complications compared to traditional surgeries.

In 2024, directional atherectomy devices dominated the market with a 39.9% share, driven by their effectiveness in treating above- and below-the-knee peripheral arterial lesions. These devices offer enhanced vessel wall preservation and better long-term patency outcomes, making them the preferred choice in vascular interventions.

Get free Sample Report@ https://www.snsinsider.com/sample-request/7433

Market Segmentation Overview

By Type:

The directional atherectomy segment leads the market, holding the largest share in 2024 due to its clinical precision and adaptability across complex plaque morphologies. The laser atherectomy segment is expected to record the fastest growth over the forecast period, as it vaporizes plaque using high-frequency ultraviolet light while minimizing the risk of embolism and vessel injury. Rising FDA approvals and technological upgrades in fiber-optic catheters are strengthening this trend.

By Application:

The market covers coronary, peripheral, and neurovascular applications. The peripheral segment dominates, attributed to the increasing prevalence of PAD and the high demand for minimally invasive vascular therapies.

By End User:

Hospitals and outpatient centers constitute the major end users. The expansion of specialized vascular centers and the availability of reimbursement programs in developed economies further boost device adoption.

Regional Insights

North America accounted for 47.5% of the global atherectomy devices market in 2024. The U.S. market, valued at USD 370.5 million in 2024, is expected to reach USD 644.3 million by 2032, at a CAGR of 7.22%. High disease prevalence, advanced healthcare infrastructure, and continuous product approvals by the FDA drive market leadership in the region. Prominent companies such as Medtronic, Abbott, and Boston Scientific continue to introduce next-generation technologies to enhance procedural outcomes.

Europe follows as the second-largest region, with countries such as Germany, France, and the UK leading in product adoption. Supportive reimbursement policies and government initiatives targeting cardiovascular diseases have positively influenced the market. Italy, Spain, and Poland are witnessing growing public-private investments in endovascular care.

The Asia-Pacific region is expected to grow at the highest rate over the forecast period. Countries such as Japan, China, and India are seeing an increase in cardiovascular disease prevalence, along with significant healthcare infrastructure expansion. Japan’s growing use of Laser and Orbital Atherectomy Devices and India’s strong government-backed NCD programs contribute to this surge. Additionally, Singapore and South Korea are emerging as innovation hubs for clinical trials and R&D in medical devices.

Latin America and the Middle East & Africa are gradually developing markets. Increased awareness of peripheral vascular diseases, combined with urbanization and private healthcare expansion, is creating new opportunities for atherectomy device manufacturers in these regions.

Key Market Drivers and Trends

1. Rising Prevalence of Peripheral Artery Disease (PAD): With millions of new PAD diagnoses annually, the demand for precise and efficient atherectomy procedures continues to escalate.
2. Technological Advancements: Innovations such as image-guided atherectomy systems and improved catheter designs enhance safety and accuracy.
3. Shift Toward Minimally Invasive Treatments: Hospitals and outpatient centers are increasingly favoring procedures that offer shorter recovery times and lower complication rates.
4. Regulatory Approvals and Clinical Trials: Continuous R&D and new FDA-approved systems are broadening clinical adoption.
5. Growing Geriatric Population: The aging demographic contributes to higher incidences of vascular disorders, increasing device demand.

Competitive Landscape

Leading players in the Atherectomy Devices Market include Medtronic, Boston Scientific Corporation, Abbott Laboratories, BD, Cardiovascular Systems Inc., Avinger, Koninklijke Philips N.V., Cordis, Terumo Medical Corporation, and Stryker Corporation. These companies are focusing on product innovation, strategic collaborations, and geographic expansion to maintain their competitive edge.

For instance, AngioDynamics initiated the AMBITION BTK clinical trial in January 2025 to evaluate its Auryon laser atherectomy system for below-the-knee PAD. Similarly, BD revised its Rotarex system usage guidelines to enhance safety in tortuous and calcified vessels.

Market Outlook

As healthcare systems increasingly adopt image-guided, catheter-based interventions, the Atherectomy Devices Market will experience accelerated growth. The growing preference for endovascular procedures over open surgeries, coupled with favorable reimbursement structures in developed economies, is expected to further drive adoption rates. The introduction of next-generation, AI-assisted atherectomy systems is likely to revolutionize the field by improving procedural precision and reducing operation times.

Buy Full Report Now: https://www.snsinsider.com/checkout/7433

FAQ

1. What is the projected market size of the Atherectomy Devices Market by 2032?

The market is expected to reach USD 1.93 billion by 2032, growing at a CAGR of 8.16% over the forecast period 2025–2032.

2. Which region dominates the Atherectomy Devices Market?

North America currently leads the market, driven by advanced healthcare infrastructure, a high prevalence of PAD, and strong R&D initiatives.

3. Which type of atherectomy device holds the largest market share?

Directional atherectomy devices held the largest share in 2024 due to their precision and ability to treat complex lesions.

4. What factors are driving the growth of the Atherectomy Devices Market?

Key drivers include the rising prevalence of PAD, growing adoption of minimally invasive procedures, technological advancements, and supportive reimbursement policies.

5. Who are the leading players in the global Atherectomy Devices Market?

Top players include Medtronic, Abbott, Boston Scientific, BD, Cardiovascular Systems Inc., and Philips N.V.

Other Trending Reports

In Vitro Fertilization [IVF] Market

Next Generation Sequencing Market

Healthcare Analytics Market

HLA Typing Market